Top of this page
Skip navigation, go straight to the content

Newsroom Overview

Newsroom

Press Release

UCB First Nine Months Interim Report 2018: UCB tracking well towards full year financial outlook29 Oct 2018

UCB First Nine Months Interim Report 2018: UCB tracking …

Read more
Bimekizumab Showed Sustained Improvements in Both Joint and Skin Outcomes for Psoriatic Arthritis Patients23 Oct 2018

Bimekizumab Showed Sustained Improvements in Both Joint and Skin Outcomes …

Read more
UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus22 Oct 2018

UCB and Biogen Announce Topline Results from a Phase 2b …

Read more

UCB Stories

Picture of a laboratory 14 Nov 2018

A different perspective on clinical studies

Read more
Picture of people discussing financial results 30 Oct 2018

UCB’s performance in line with expectations for 2018

Read more
generic picture of psoriasis 29 Oct 2018

World Psoriasis Day: UCB joins patient advocates in call for …

Read more

Social Media